Sanochemia/SPL: Iron-Based MRI Agent Meets Phase III Endpoints
25 Feb 2025 //
PR NEWSWIRE
Sanochemia: New contrast agent aims to detect the smallest lymphatic metastases
17 Apr 2024 //
PR NEWSWIRE
Sanochemia Pharmazeutika AG On Health Canada Inspection List
08 Aug 2018 //
HEALTH CANADA